By binding to the miRNA promoter, RUNX1 increases the transcriptional level of miR-27a in breast cancer and concomitantly the decreases expression of ZBTB10, a direct target gene of miR-27a, to promote endothelial differentiation and subsequent angiogenesis and tumor metastasis [120]. The gene discussed is ZBTB10; the disease is breast cancer.